TIMES SHOWN IN EDT*

8:30 am Registration & Morning Coffee

8:50 am Chairperson Opening Remarks

  • David Kyle Chairman & CEO, Evolve Biosystems, Chair

Harnessing the Infant Microbiome as a Preventative Treatment

9:00 am Exploring How the Infant Microbiome Offers a Window of Opportunity for the Prevention of Chronic Conditions

  • Alessio Fasano Chief, Pediatric Gastroenterology & Nutrition, Massachusetts General Hospital

9:30 am Targeting the Microbiome to Intercept Childhood Diseases

  • Richard Insel Global Head, Healthy Baby Initiative, Johnson & Johnson

10:00 am Investment in early life would benefit society as a whole. Together, we can make a contribution to future health

10:10 am Morning Refreshments

10:40 am Speed Networking

Examining the Relationship Between the Microbiome, Allergies & the Immune System

11:10 am Therapeutic Microbiome Manipulation for Treatment & Prevention of Food Allergy

  • Rose Szabady Associate Director, Immunology, Vedanta Bioscience

11:40 am Early Life Immune Education by Gut Microbes

  • Nitya Jain Principal Investigator, Harvard Medical School

12:10 pm Cross-Reactive Antibodies to SARS-Cov-2: A Potential Broad Protection Against COVID-19 & Future Coronavirus Infections

12:40 pm Lunch

Successfully Modulating the Microbiome Through Nutritional Interventions

1:40 pm Examining Nutrition as the Key Determinant of Age-Appropriate Microbiota Development in Infants and Children

2:10 pm Food, Microbes & the Gut for Good Growth in Global Health

  • Chris Damman Senior Program Officer, Global Health, Bill & Melinda Gates Foundation

Utilizing the Microbiome to Improve Early Life Outcomes

2:40 pm The Importance of a B. Infantis Dominant Infant Gut Microbiome in Protection from Opportunistic Infections in Term & Pre-term Infants

  • David Kyle Chairman & CEO, Evolve Biosystems, Chair

3:10 pm Understanding Gut Health During Early Life

3:40 pm Afternoon Refreshments & Poster Session

4:10 pm Using Precision Diagnostics to Improve Treatment of Infectious Diseases at a Young Age

4:40 pm Speed Learning

Supercharge your knowledge in a range of topics by this speed learning hour

16:40 Examing the Effect the use of Antibiotics Has on the Infant Microbiome

Dorrotya Nagy-Szakal
CMO
Biotia, Inc.

16:55 Exploring the Role of FMT as an Infant Microbiome Therapeutics

Stacy Kahn
Attending Physician, Division
of Gastroenterology
Hepatology and Nutrition
Boston Children’s Hospital

17:10 Assessing the Gut-Brain Axis in Infants

Xue-Jun (June) Kong
Research Investigator
Massachusetts General
Hospital

17:25 A Joint Q&A Panel for Further Discussion

Dorrotya Nagy-Szakal
CMO
Biotia, Inc.
Stacy Kahn
Attending Physician, Division
of Gastroenterology
Hepatology and Nutrition
Boston Children’s Hospital
Xue-Jun (June) Kong
Research Investigator
Massachusetts General
Hospital

5:40 pm Chairperson Closing Remarks

  • David Kyle Chairman & CEO, Evolve Biosystems, Chair

5:50 pm End of Conference Day One